FDA Approves Abatacept for Pediatric Patients With Psoriatic

As many as 5% of pediatric patients with juvenile idiopathic arthritis are estimated to have juvenile PsA.

Related Keywords

Steven Taylor , Carlos Dortrait , Drug Administration , Arthritis Foundation , Bristol Myers Squibb , Psoriatic Arthritis , Arthritis , Oint Inflammation , Rheumatoid Arthritis , A , Juvenile Rheumatoid Arthritis , Bone And Joint Bones Joints Amp , Autoimmune Disease , Children , Child , Childhood , Ediatrics , Kids , Adolescent Medicine , Us Food And Drug Administration , Nited States Food And Drug Administration , Fda , Immunology , Intravenous Iv , Intravenous , Tv , Pharmacokinetics ,